311 related articles for article (PubMed ID: 19015958)
1. Antisense makes sense in engineered regenerative medicine.
Yao Y; Wang C; Varshney RR; Wang DA
Pharm Res; 2009 Feb; 26(2):263-75. PubMed ID: 19015958
[TBL] [Abstract][Full Text] [Related]
2. Antisense strategies in degenerative joint diseases: sense or nonsense?
Huber LC; Distler O; Gay RE; Gay S
Adv Drug Deliv Rev; 2006 May; 58(2):285-99. PubMed ID: 16574269
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic antisense and ribozymes.
Rossi JJ
Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645
[TBL] [Abstract][Full Text] [Related]
4. [Bone tissue regeneration using stem cells].
Kotobuki N; Ohgushi H
Clin Calcium; 2008 Dec; 18(12):1685-91. PubMed ID: 19043180
[TBL] [Abstract][Full Text] [Related]
5. The potential application of ribozymes for the treatment of hematological disorders.
James HA
J Leukoc Biol; 1999 Sep; 66(3):361-8. PubMed ID: 10496304
[TBL] [Abstract][Full Text] [Related]
6. Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are?
Kim KH; Park KK
World J Gastroenterol; 2014 Oct; 20(40):14696-705. PubMed ID: 25356032
[TBL] [Abstract][Full Text] [Related]
7. Cardiac stem cell trials and the new world of cellular reprogramming: Time to move on.
Rosengart TK; Patel V; Sellke FW
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1642-1646. PubMed ID: 29397153
[No Abstract] [Full Text] [Related]
8. Antisense applications for biological control.
Pan WH; Clawson GA
J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307
[TBL] [Abstract][Full Text] [Related]
9. Strategies to identify potential therapeutic target sites in RNA.
Lützelberger M; Kjems J
Handb Exp Pharmacol; 2006; (173):243-59. PubMed ID: 16594619
[TBL] [Abstract][Full Text] [Related]
10. Anti-genes: siRNA, ribozymes and antisense.
Scanlon KJ
Curr Pharm Biotechnol; 2004 Oct; 5(5):415-20. PubMed ID: 15544489
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells.
Miyagishi M; Hayashi M; Taira K
Antisense Nucleic Acid Drug Dev; 2003 Feb; 13(1):1-7. PubMed ID: 12691531
[TBL] [Abstract][Full Text] [Related]
12. The Future of Cardiovascular Regenerative Medicine.
Lee RT; Walsh K
Circulation; 2016 Jun; 133(25):2618-25. PubMed ID: 27324357
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic oligonucleotides.
Goodchild J
Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
[TBL] [Abstract][Full Text] [Related]
14. Antisense technology: an emerging platform for cardiovascular disease therapeutics.
Lee RG; Crosby J; Baker BF; Graham MJ; Crooke RM
J Cardiovasc Transl Res; 2013 Dec; 6(6):969-80. PubMed ID: 23856914
[TBL] [Abstract][Full Text] [Related]
15. Nucleic acid modulation of gene expression: approaches for nucleic acid therapeutics against cancer.
Nakata Y; Kim TK; Shetzline S; Gewirtz AM
Crit Rev Eukaryot Gene Expr; 2005; 15(2):163-82. PubMed ID: 16022634
[TBL] [Abstract][Full Text] [Related]
16. Making sense of antisense.
Murakami A
Trends Mol Med; 2001 Oct; 7(10):430-1. PubMed ID: 11597507
[No Abstract] [Full Text] [Related]
17. Therapeutic potential of oligonucleotide-based therapy in cardiovascular disease.
Morishita R; Kaneda Y; Ogihara T
BioDrugs; 2003; 17(6):383-9. PubMed ID: 14614761
[TBL] [Abstract][Full Text] [Related]
18. Prospects of siRNA applications in regenerative medicine.
Mottaghitalab F; Rastegari A; Farokhi M; Dinarvand R; Hosseinkhani H; Ou KL; Pack DW; Mao C; Dinarvand M; Fatahi Y; Atyabi F
Int J Pharm; 2017 May; 524(1-2):312-329. PubMed ID: 28385649
[TBL] [Abstract][Full Text] [Related]
19. General Overview of the 14th International Symposium on Stem Cell Therapy and Cardiovascular Innovations: Working Progress of a Global Initiative in 2017.
Sanz-Ruiz R; Climent AM; Fernández-Santos ME; Villa Arranz A; Gutiérrez Ibañes E; Vázquez-Álvarez ME; Fernández-Avilés F
Circ Res; 2017 Oct; 121(9):1040-1043. PubMed ID: 29025758
[No Abstract] [Full Text] [Related]
20. Enhancing stem cell survival in vivo for tissue repair.
Hyun JS; Tran MC; Wong VW; Chung MT; Lo DD; Montoro DT; Wan DC; Longaker MT
Biotechnol Adv; 2013; 31(5):736-43. PubMed ID: 23153460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
